Are Critical Bloggers “Enemies” of Pharma?
More and more attention is being paid to bloggers in the Pharma BlogospherTM. There are currently several means of keeping track of all the comings and goings of blogs in this...
Giuliani, OxyContin, Big Pharma, and Terrorism
My mother-in-law would freak if she read Ed Silverman's Pharmalot Blog piece "OxyContin And...Our Next President?" connecting the OxyContin/Purdue Pharma criminals to presidential candidate Rudy Giuliani, who some people equate with...
Pharma Marketing Blog Gets Another Top 5 “Must Read” Rating!
Have you seen the premier issue of BioTech360 from the publishers of The Scientist? It was launched this week at BIO.What I find notable about it, aside from its "sophisticated break-through...
Gardasil: Less Hype May Help
As reported in today's Wall Street Journal:"An editorial published in the New England Journal of Medicine raises questions about the overall effectiveness of Merck & Co.'s cervical-cancer vaccine, Gardasil, and advises...
Dollars for Docs: More Scrutiny Needed
My fellow blogger Peter Rost over at Question Authority continues to milk an Astrazeneca internal newsletter for stories. First it was the Zubillaga Affair, then the Missy Moran's MUMS Miasma, followed...
Imagine There’s No DTC. I Wonder If You Can.
With apologies to John Lennon:Imagine there's no DTCIt's easy if you tryNo bellowing at usFrom airwaves in the skyImagine all the marketersOut of work that very dayImagine there's no FDAIt isn't...
Guidelines for Gifts to Patients
Some time ago, I suggested that pharma sales reps should bring free lunch to patients as well as physicians and their staffs (see "Free lunch for patients! Why not?").I never thought...
BiDil Sales Disappoint: Blame Genes or Marketing?
Jim Edwards, editor at Brandweek and author the BrandweekNRX blog, reports that sales of BiDil, a heart failure drug for African Americans, "suck." His opinion as to why this is so:...
Zimulti Joke Contest
Ed and his wife have just sat down to a table at a fancy Italian restaurant. The waiter comes over and asks them a question.Ed doesn't quite get the last part...
Yummi! It’s Zimulti!
According to the Acomplia Report, "It's now official. If diet drug Acomplia (rimonabant) is ultimately approved for sale in the United States, the prescription diet pill will go on the U.S....